# ExosomeDx in MRI-negative Men With High PSA

> **NCT06966089** · NA · NOT_YET_RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 425 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Urinary ExoDx test
- **DIAGNOSTIC_TEST:** Transrectal ultrasound-guided prostate biopsy
- **DIAGNOSTIC_TEST:** Transperineal 12-core prostate biopsy

## Key facts

- **NCT ID:** NCT06966089
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 425 (ESTIMATED)
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966089, "ExosomeDx in MRI-negative Men With High PSA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06966089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*